Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.

February 24, 2021
Open Access

DNase1L3 suppresses hepatocellular carcinoma growth via inhibiting complement autocrine effect.

Neoplasma
Qing-Yun ChenDa-Qin Suo
February 23, 2021
Preprint
Open Access

Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection.

BioRxiv : the Preprint Server for Biology
L. MaHrishikesh S Kulkarni
February 23, 2021
Open Access

C3 and alternative pathway components are associated with an adverse lipoprotein subclass profile: The CODAM study.

Journal of Clinical Lipidology
Ying XinMarleen M J van Greevenbroek
February 23, 2021
Open Access

Alzheimer's Risk Gene TREM2 Determines Functional Properties of New Type of Human iPSC-Derived Microglia.

Frontiers in Immunology
Marvin ReichMarkus Britschgi
February 23, 2021
Open Access

Complement Factor I Mutation May Contribute to Development of Thrombotic Microangiopathy in Lupus Nephritis.

Frontiers in Medicine
Min-Hua TsengJing-Long Huang
February 23, 2021
Open Access

Establishing a Case for Anti-complement Therapy in Membranous Nephropathy.

KI Reports
Isabelle AyoubBrad H Rovin
February 23, 2021

The role of complement in brain injury following intracerebral hemorrhage: A review.

Experimental Neurology
Katherine HolsteGuohua Xi
February 19, 2021

Neuropathological spectrum in systemic lupus erythematosus: A single institute autopsy experience.

Journal of Neuroimmunology
Balamurugan ThirunavukkarasuBishan Dass Radotra
February 20, 2021
Review
Open Access

Emerging recognition of the complement system in hepatic ischemia/reperfusion injury, liver regeneration and recovery (Review).

Experimental and Therapeutic Medicine
Zhi-Gao HuSong-Qing He
February 20, 2021

The complement pathway is activated in people with HIV and is associated with non-AIDS comorbidities.

The Journal of Infectious Diseases
I Vujkovic-CvijinI Sereti
February 19, 2021
Review

[State of art and new perspectives in the induction regimen of ANCA-associated vasculitis with renal involvement: from histopathology to therapy].

Giornale italiano di nefrologia : organo ufficiale della Società italiana di nefrologia
Martina Uzzo, Federico Alberici
February 19, 2021
Open Access

Interleukin-33 Amplifies Human Mast Cell Activities Induced by Complement Anaphylatoxins.

Frontiers in Immunology
Peter W WestSilvia Bulfone-Paus
February 18, 2021

Inhibition of the classical pathway of complement activation impairs bacterial clearance during Enterococcus faecalis infection.

Infection and Immunity
Eman M Rabie Shehab El-DinRamadan Hassan
February 18, 2021

Avacopan for the Treatment of ANCA-Associated Vasculitis.

The New England Journal of Medicine
David R W JayneADVOCATE Study Group
February 17, 2021
Preprint
Open Access

Deep Pathological Phenotyping of Dermatomyositis with Different Autoantibodies

ResearchSquare
Li ZengWen-hua Zhu

Sign up to follow this feed and discover related papers.

Related Feeds

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Basophils

Basophils are myeloid cells with a high affinity IgE receptor and is involved in inflammatory responses during allergy. Discover the latest research on Basophils here.

Classical Complement Pathway

The Classical Complement Pathway is activated by antigen-antibody complexes. Activation of this pathway leads to the generation of the membrane attack complex, which kills pathogenic cells. Discover the latest research on the Classical Complement Pathway here.

Complement Pathway: Mannose-Binding Lectin

The Mannose-Binding Lectin Complement Pathway is activated when mannose-binding lectin binds to mannose found on the surface of pathogens. Subsequent complement activation is similar to the classical complement pathway, but without the need for antigen-antibody complexes. Discover the latest research here.

Inflammation Mediators

Inflammation Mediators include cytokines, prostaglandins and other molecules that ochestrate the inflammatory process in response to injury, allergy or pathogens. Discover the latest research on Inflammation Mediators here.

Innate Immunity and CNS

Innate immune responses in the CNS are carried out by microglia and astrocytes. Here is the latest research on mechanisms underlying innate immunity in the CNS and its impact on neurophysiology.

Innate Immunity in Lower Organisms

Many components of the mammalian innate immune system have homologs in lower organisms, such as invertebrates. Discover the latest research on Innate Immunity in Lower Organisms here.

Innate Immunity: Neurodegeneration

The innate immune system is a first line of defense against infection. Pathological states can occur if there is over activation of the innate immune system, particularly in the brain. The excessive activation of these cells can lead to inflammation and neurodegenerative diseases. Here is the latest research on innate immunity and neurodegeneration.

Intracellular Killing

Intracellular killing involves the death of microbes within the phagocyte. Here is the latest research on intracellular killing.

Killer Cells

Natural killer cells express inhibitory receptors specific for mhc class i proteins and stimulatory receptors with diverse specificities. Here is the latest research on natural killer cells.

© 2021 Meta ULC. All rights reserved
/feed-previews/alternative-complement-pathway/63f3790e-8505-4a10-a370-9552022248e2